These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21465311)
41. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. Aichele P; Unsoeld H; Koschella M; Schweier O; Kalinke U; Vucikuja S J Immunol; 2006 Apr; 176(8):4525-9. PubMed ID: 16585541 [TBL] [Abstract][Full Text] [Related]
42. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237 [TBL] [Abstract][Full Text] [Related]
43. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110 [TBL] [Abstract][Full Text] [Related]
44. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. Ehl S; Hombach J; Aichele P; Rülicke T; Odermatt B; Hengartner H; Zinkernagel R; Pircher H J Exp Med; 1998 Mar; 187(5):763-74. PubMed ID: 9480986 [TBL] [Abstract][Full Text] [Related]
45. Antioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection. Laniewski NG; Grayson JM J Virol; 2004 Oct; 78(20):11246-57. PubMed ID: 15452243 [TBL] [Abstract][Full Text] [Related]
46. Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers. Savage P; Millrain M; Dimakou S; Stebbing J; Dyson J Tumour Biol; 2007; 28(2):70-6. PubMed ID: 17264539 [TBL] [Abstract][Full Text] [Related]
47. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385 [TBL] [Abstract][Full Text] [Related]
48. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice. Razvi ES; Welsh RM; McFarland HI J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281 [TBL] [Abstract][Full Text] [Related]
49. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Whitmire JK; Murali-Krishna K; Altman J; Ahmed R Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):373-9. PubMed ID: 10794058 [TBL] [Abstract][Full Text] [Related]
50. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus. Christensen JP; Bartholdy C; Wodarz D; Thomsen AR J Immunol; 2001 Mar; 166(5):3384-91. PubMed ID: 11207295 [TBL] [Abstract][Full Text] [Related]
51. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection. Blass E; Aid M; Martinot AJ; Larocca RA; Kang ZH; Badamchi-Zadeh A; Penaloza-MacMaster P; Reeves RK; Barouch DH J Virol; 2018 Jun; 92(11):. PubMed ID: 29514912 [TBL] [Abstract][Full Text] [Related]
52. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion. Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703 [TBL] [Abstract][Full Text] [Related]
53. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control. Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230 [TBL] [Abstract][Full Text] [Related]
54. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081 [TBL] [Abstract][Full Text] [Related]
55. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes. Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756 [TBL] [Abstract][Full Text] [Related]
56. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342 [TBL] [Abstract][Full Text] [Related]
57. In vivo RNA interference screens identify regulators of antiviral CD4(+) and CD8(+) T cell differentiation. Chen R; Bélanger S; Frederick MA; Li B; Johnston RJ; Xiao N; Liu YC; Sharma S; Peters B; Rao A; Crotty S; Pipkin ME Immunity; 2014 Aug; 41(2):325-38. PubMed ID: 25148027 [TBL] [Abstract][Full Text] [Related]
58. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Bachmann MF; Kündig TM; Hengartner H; Zinkernagel RM Proc Natl Acad Sci U S A; 1997 Jan; 94(2):640-5. PubMed ID: 9012837 [TBL] [Abstract][Full Text] [Related]
59. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice. Quinn DG; Zajac AJ; Hioe CE; Frelinger JA J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195 [TBL] [Abstract][Full Text] [Related]
60. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses. Bocharov GA J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]